Completed
Mechanism of Action of High-Dose IL-2 (Aldesleukin) in Metastatic Melanoma and Kidney Cancer
NCT00304460
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +24 more
- Locations
-
- National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States